US OptionsDetailed Quotes
LLY241129C615000
- 0.00
- 0.000.00%
15min DelayClose Nov 26 09:30 ET
0.00High0.00Low
0.00Open0.00Pre Close0 Volume0 Open Interest615.00Strike Price0.00Turnover160.03%IV-22.08%PremiumNov 29, 2024Expiry Date174.32Intrinsic Value100Multiplier3DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type0.9735Delta0.0006Gamma4.49Leverage Ratio-0.9904Theta0.0414Rho4.37Eff Leverage0.0405Vega
Eli Lilly and Co Stock Discussion
"By issuing the proposal in its waning days, the Biden administration is leaving Trump health officials with the political dilemma of whether to go ahead with an expensive proposal popular with some supporters or to cancel plans while the administration pursues tax cuts."
Unquote:
I wonder if you read carefully. Musk wasn't wrong when he mentioned lazy posting lately. Trump health officials is the hhs who believed vax causes autism, not believe in germs, flouride, etc and the doge not do...
If you can't tell yet that something smells fishy for the timing of the WSJ news about Biden passing law for Medicare accepting fatloss drug on holiday week. Then you deserve what is going to happen next.
It’s unusual for a major policy like expanding Medicare and Medicaid to cover weight-loss drugs to be proposed 30 days before a presidential term ends. Such changes require legislative approval or regulatory adjustments, both of w...
Gapping up
$Poseida Therapeutics (PSTX.US)$' stock jumped over 200%. This happened because Roche, a Swiss company, is buying Poseida for up to $1.5 billion in cash.
Shares of weight-loss drug maker $Novo-Nordisk A/S (NVO.US)$ and $Eli Lilly and Co (LLY.US)$ rose 2.1% and 4.9% respectively on Tuesday as U.S. President Jo Biden proposed expanding coverage of anti-obesity drugs for millions on Medicare and Medicaid...
Mark my word, if LLY close this week anyway below 745.26 it is done!
To quietly take down LLY!
We will see very soon.
No comment yet